派博傳思國(guó)際中心

標(biāo)題: Titlebook: Immunotherapy of Disease; T. J. Hamblin Book 1989 Kluwer Academic Publishers 1989 blood.immunoglobulin.immunotherapy.interferon.transplant [打印本頁(yè)]

作者: 僵局    時(shí)間: 2025-3-21 17:28
書(shū)目名稱Immunotherapy of Disease影響因子(影響力)




書(shū)目名稱Immunotherapy of Disease影響因子(影響力)學(xué)科排名




書(shū)目名稱Immunotherapy of Disease網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Immunotherapy of Disease網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Immunotherapy of Disease被引頻次




書(shū)目名稱Immunotherapy of Disease被引頻次學(xué)科排名




書(shū)目名稱Immunotherapy of Disease年度引用




書(shū)目名稱Immunotherapy of Disease年度引用學(xué)科排名




書(shū)目名稱Immunotherapy of Disease讀者反饋




書(shū)目名稱Immunotherapy of Disease讀者反饋學(xué)科排名





作者: exceed    時(shí)間: 2025-3-21 22:51
Intravenous Immunoglobulin,s were prepared from animal serum during the 1920s, and subsequently used in the treatment of pneumococcal infections.. During the Second World War, alcohol fractionation methods developed by Cohn in the USA enabled large-scale extraction of gammaglobulins from human plasma. However, this so-called
作者: AUGUR    時(shí)間: 2025-3-22 01:46

作者: 大罵    時(shí)間: 2025-3-22 06:29

作者: adequate-intake    時(shí)間: 2025-3-22 10:18

作者: regale    時(shí)間: 2025-3-22 15:43
Modifications of Monoclonal Antibody for Immunotherapy,ng out the enemy’., their use as immunotherapeutic agents has been disappointing. A variety of monoclonal antibodies used against a number of diverse tumours have produced only transient responses.. In the particular system with which our group has been working, the use of monoclonal antiidiotype an
作者: 身心疲憊    時(shí)間: 2025-3-22 17:35

作者: Cumbersome    時(shí)間: 2025-3-22 22:22

作者: sphincter    時(shí)間: 2025-3-23 05:07
A. C. Newland,P. A. Veysphy. Indeed, good-quality conventional venography has long been a challenging procedure for several reasons. First, unlike arteriography, where smaller distal branches are visualized from a central injection in a larger artery, the vein in question or one of its smaller tributaries needs to be direc
作者: BARGE    時(shí)間: 2025-3-23 07:10

作者: 有害    時(shí)間: 2025-3-23 12:43

作者: 分散    時(shí)間: 2025-3-23 15:19
C. D. Puseyll vascular territories, and the incidence increases with age. Responsible for different severe clinical findings, it is also the major cause of cerebrovascular disease. In the CNS it is the main cause of stroke, which is fatal in about 40% of cases [.]. However, every year approximately 20 million
作者: 干涉    時(shí)間: 2025-3-23 20:43

作者: inconceivable    時(shí)間: 2025-3-24 00:37

作者: 輕率看法    時(shí)間: 2025-3-24 04:56

作者: 知道    時(shí)間: 2025-3-24 08:38

作者: 同音    時(shí)間: 2025-3-24 10:41

作者: Recessive    時(shí)間: 2025-3-24 16:11
ring from cow pox, using his wife‘s knitting needle as a vaccinating implement. It has made slow progress. Meanwhile the science of Immunology has burgeoned so much that if all immunologists read every page of the Journal of Immunology, let alone the other Immunology journals, then they would have n
作者: 可耕種    時(shí)間: 2025-3-24 20:08
Immunological Effects of Blood Transfusion,dures, the support of patients with neoplastic diseases, and the maintenance of patients with chronic anaemias, are some examples of therapies that would be impossible without the availability of blood for transfusion. Thus, reliance on transfusion support has been routine, and perhaps casual.
作者: Atmosphere    時(shí)間: 2025-3-25 02:12

作者: Gerontology    時(shí)間: 2025-3-25 06:07

作者: meditation    時(shí)間: 2025-3-25 09:20

作者: 牙齒    時(shí)間: 2025-3-25 15:41
Intravenous Immunoglobulin,‘standard immunoglobulin’ or ‘human normal immunoglobulin’ (HNI) caused undesirable side-effects when administered intravenously., and therefore for several decades was given by intramuscular injection, mainly as prophylaxis against endemic viral disease.
作者: 很像弓]    時(shí)間: 2025-3-25 18:33

作者: 詞根詞綴法    時(shí)間: 2025-3-25 20:22

作者: 遠(yuǎn)地點(diǎn)    時(shí)間: 2025-3-26 00:18
Immunology and Medicinehttp://image.papertrans.cn/i/image/462309.jpg
作者: 控制    時(shí)間: 2025-3-26 05:28

作者: 包租車船    時(shí)間: 2025-3-26 11:08

作者: cathartic    時(shí)間: 2025-3-26 13:00

作者: 埋葬    時(shí)間: 2025-3-26 20:06
t. Happily things are changing. The nine chapters of this volume detail nine quite different approaches to manipulating the immune system for therapeutic benefit. All are experimental and they have been attended with greater or lesser degrees of success. In some cases their main effect has been to elucidate t978-94-010-7322-6978-94-009-1844-3
作者: esthetician    時(shí)間: 2025-3-26 20:58
A. C. Newland,P. A. Veysnd intermittent application of tourniquets [.]. Furthermore, the study of large central veins requires simultaneous bilateral limb injections in order to opacify these capacious low-pressure vessels, for example, bilateral arm injections to show the SVC ..
作者: 并排上下    時(shí)間: 2025-3-27 01:42

作者: 完成才能戰(zhàn)勝    時(shí)間: 2025-3-27 08:16
A. J. Bell basic techniques, safety, efficacy, image processing, and pharmacoeconomic details, to successfully implement a new level of MRA image quality with this new contrast agent. In addition to improving all the usual arterial phase MRA - plications, the blood pool distribution opens up new possibilities, includin978-3-642-09666-2978-3-540-77861-5
作者: 不出名    時(shí)間: 2025-3-27 10:21

作者: 柔聲地說(shuō)    時(shí)間: 2025-3-27 17:37

作者: Hemiplegia    時(shí)間: 2025-3-27 21:09
T. J. Hambline, usually at the carotid bifurcation, is the most common identifiable cause of carotid artery stenosis [.], present in about 25% of all strokes [.]. In patients with significant stenoses (i.e., >70% luminal narrowing) there are a variety of therapeutic options, including carotid endarterectomy or c
作者: 飛鏢    時(shí)間: 2025-3-27 23:55

作者: 牛的細(xì)微差別    時(shí)間: 2025-3-28 03:28

作者: BLINK    時(shí)間: 2025-3-28 08:36

作者: 闡明    時(shí)間: 2025-3-28 12:21

作者: Ambulatory    時(shí)間: 2025-3-28 15:41

作者: Exposure    時(shí)間: 2025-3-28 19:13

作者: 參考書(shū)目    時(shí)間: 2025-3-29 01:13





歡迎光臨 派博傳思國(guó)際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
农安县| 衡山县| 侯马市| 冷水江市| 讷河市| 巴彦淖尔市| 醴陵市| 自贡市| 阜康市| 长春市| 锦屏县| 南丰县| 台州市| 望奎县| 民权县| 温州市| 扶余县| 利川市| 民丰县| 高阳县| 宣武区| 抚顺县| 易门县| 仁布县| 晋州市| 宕昌县| 新丰县| 襄樊市| 奉新县| 万荣县| 昌都县| 寿光市| 宁蒗| 佛冈县| 镇康县| 怀仁县| 灵武市| 珲春市| 宁陵县| 行唐县| 清新县|